Trial Profile

Limited Stage Small Cell Lung Cancer (LS-SCLC): A Phase III Randomized Study of Chemoradiation Versus Chemoradiation Plus Atezolizumab

Status: Active, no longer recruiting

Phase of Trial: Phase II/III

Latest Information Update: 03 Nov 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Atezolizumab (Primary) ; Carboplatin; Cisplatin; Etoposide
Indications Small cell lung cancer
Focus Therapeutic Use

Most Recent Events

12 Jun 2025 The protocol has been amended to change in study time frame for its primary endpoint.
12 Jun 2025 Planned End Date changed from 13 Aug 2025 to 21 Feb 2026.
22 Aug 2024 Planned End Date changed from 1 Aug 2025 to 13 Aug 2025.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com